Your browser doesn't support javascript.
loading
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13.
Yoo, Kwai Han; Lee, Su Jin; Cho, Jinhyun; Lee, Ki Hyeong; Park, Keon Uk; Kim, Ki Hwan; Cho, Eun Kyung; Choi, Yoon Hee; Kim, Hye Ryun; Kim, Hoon-Gu; Ahn, Heui June; Lee, Ha Yeon; Yun, Hwan Jung; Kang, Jin-Hyoung; Jeong, Jaeheon; Choi, Moon Young; Jung, Sin-Ho; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju.
Affiliation
  • Yoo KH; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee SJ; Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Cho J; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee KH; Division of Hematology-Oncology, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
  • Park KU; Division of Medical Oncology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
  • Kim KH; Department of Hematology/Oncology, Keimyung Unversity Dongsan Hospital, Daegu, Korea.
  • Cho EK; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
  • Choi YH; Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Kim HR; Division of Hematology and Oncology, Department of Internal Medicine, Dongnam Institute of Radiological and Medical Sciences, Busan, Korea.
  • Kim HG; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Ahn HJ; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Lee HY; Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
  • Yun HJ; Division of Hematology and Oncology, Department of Internal Medicine, National Medical Center, Seoul, Korea.
  • Kang JH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
  • Jeong J; Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Choi MY; Division of Medical Oncology and Hematology, Department of Internal Medicine, Kyunghee University Hospital, Seoul, Korea.
  • Jung SH; Division of Hematology and Oncology, Department of Internal Medicine, Inje University Paik Hospital, Busan, Korea.
  • Sun JM; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Lee SH; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn JS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park K; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn MJ; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cancer Res Treat ; 51(2): 718-726, 2019 Apr.
Article de En | MEDLINE | ID: mdl-30177585
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome pulmonaire non à petites cellules / Tumeurs du poumon / Mutation Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Female / Humans / Male Langue: En Journal: Cancer Res Treat Année: 2019 Type de document: Article Pays de publication:
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome pulmonaire non à petites cellules / Tumeurs du poumon / Mutation Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Female / Humans / Male Langue: En Journal: Cancer Res Treat Année: 2019 Type de document: Article Pays de publication: